Harrow Inc. (HROW)
HROW trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$28.24
-2.99% on the day
Market cap
$1.1B
Small cap
Revenue · 2025
$272.3M
+36.4% on 2024
Net income · 2025
-$5.1M
-1.9% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | HROW on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001360214 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $272.3M |
| Net income | -$5.1M |
| Operating income | $30.5M |
| Net margin | -1.9% |
| Operating margin | 11.2% |
| Revenue growth | +36.4% |
| Cash | $72.9M |
| Total assets | $399.5M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 3.9× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2023-07-19 |
| Latest annual report | 10-K | 2026-03-02 |
| Latest quarterly / interim | 10-Q | 2026-08-10 |
| Latest current report | 8-K | 2026-10-05 |
| Latest proxy | DEFA14A | 2026-04-24 |
Source: SEC EDGAR submissions feed, 867 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -11.0% |
| 1 month | -19.5% |
| 3 months | -39.3% |
| Year to date | -44.4% |
| 1 year | -29.7% |
| From 52-week high | -50.3% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| AVLN | Avalyn Pharma Inc. | $23.74 | -4.27% | $1.1B |
| JANX | Janux Therapeutics Inc. | $17.18 | -5.34% | $1.1B |
| LTGO | Latigo Biotherapeutics Inc. | $15.71 | -1.94% | $1.0B |
| NBTX | Nanobiotix S.A. | $21.49 | -8.16% | $1.1B |
| AMPH | Amphastar Pharmaceuticals Inc. | $26.05 | -2.65% | $1.1B |
| LBRX | LB Pharmaceuticals Inc | $34.79 | -3.17% | $1.1B |
| TRAX | First Tracks Biotherapeutics Inc. Ordinary Shares | $31.68 | -6.96% | $1.1B |
| OPK | OPKO Health Inc. | $1.32 | -4.35% | $985.2M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier